Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

331
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
331
Depression: Overview01:18

Depression: Overview

634
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
634
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

666
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
666

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetics of major depressive disorder in a homogeneous population with uniform phenotyping.

Molecular psychiatry·2026
Same author

Shared genetic risk between functional somatic syndromes, internalizing disorders, and immune-mediated diseases: a twin-sibling study.

Brain, behavior, and immunity·2026
Same author

Indirect Genetic Effects on Alcohol Use Disorder and Nicotine Dependence.

medRxiv : the preprint server for health sciences·2026
Same author

Prevalence of internalizing disorders, symptoms, and traits across age using advanced nonlinear models - ERRATUM.

Psychological medicine·2026
Same author

Symptom-specific genetics reveal heterogeneity within major depressive disorder.

medRxiv : the preprint server for health sciences·2026
Same author

Genetic nurture in intergenerational transmission of substance use.

Nature communications·2026

Related Experiment Video

Updated: Dec 13, 2025

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.8K

Data mining algorithm predicts a range of adverse outcomes in major depression.

Hanna M van Loo1, Tim B Bigdeli2, Yuri Milaneschi3

  • 1Department of Psychiatry, University of Groningen, University Medical Center Groningen, Hanzeplein 1 (PO Box 30.001), 9700 RB Groningen, the Netherlands.

Journal of Affective Disorders
|August 4, 2020
PubMed
Summary

A new data mining algorithm accurately predicts future major depression (MD) episodes and related conditions. This model offers personalized treatment by outperforming traditional risk factors for severe illness.

Keywords:
Course of illnessData mining, predictionMajor depressionRecurrenceReplication

More Related Videos

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

3.0K
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.4K

Related Experiment Videos

Last Updated: Dec 13, 2025

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.8K
Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

3.0K
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.4K

Area of Science:

  • Psychiatry and Mental Health
  • Computational Psychiatry
  • Clinical Epidemiology

Background:

  • Major depression (MD) exhibits varied illness courses, complicating treatment decisions.
  • A 'one-size-fits-all' approach risks under- or overtreatment.
  • Data mining offers potential for personalized treatment prediction models.

Purpose of the Study:

  • To assess a data mining algorithm's performance in predicting future MD episodes.
  • To evaluate the model's ability to predict anxiety disorders and disability.
  • To compare the model's predictive accuracy against established risk factors.

Main Methods:

  • Applied a prediction model using baseline clinical data to two independent test samples (n=4226).
  • Assessed prediction of future MD episodes, anxiety disorders, and disability over 1-9 years.
  • Compared model performance with known risk factors for severe MD course.

Main Results:

  • The model consistently predicted future MD episodes in both samples (AUC 0.68-0.73).
  • It accurately predicted generalized anxiety disorder, panic disorder, and disability (AUC 0.65-0.78).
  • Prediction accuracy surpassed that of family history and lifetime trauma for severe illness.

Conclusions:

  • The validated prediction model demonstrates consistent performance across diverse populations and settings.
  • This tool shows promise for enhancing clinical decision-making in MD treatment.
  • Replication across different subpopulations and measurement procedures strengthens clinical applicability.